AMARIN CORP PLC -ADR (AMRN:NASDAQ)
$15.25 0.35 (2.349%)
Analysed AMARIN CORP PLC -ADR (AMRN:NASDAQ) News Sources
Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN)
27-05-2026
advfn.com
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
28-05-2026
yahoo.com
Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case
04-06-2026
yahoo.com
Update: Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case
04-06-2026
yahoo.com
Sector Update: Healthcare Stocks Climb Late Afternoon
04-06-2026
yahoo.com
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma
04-06-2026
yahoo.com
Generic drugmakers gain key victory in ‘skinny label’ patent case
05-06-2026
biopharmadive.com
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
08-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
09-06-2026
yahoo.com
Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?
12-06-2026
yahoo.com
What is the current price of AMARIN CORP PLC -ADR (AMRN:NASDAQ)?
The current price of AMARIN CORP PLC -ADR (AMRN:NASDAQ) is $15.25.
AMARIN CORP PLC -ADR (AMRN:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMARIN CORP PLC -ADR (AMRN:NASDAQ) since the previous trading day is $0.35.
AMARIN CORP PLC -ADR (AMRN:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMARIN CORP PLC -ADR (AMRN:NASDAQ) since the previous trading day is 2.349%.
What is the most recent average sentiment score for AMARIN CORP PLC -ADR (AMRN:NASDAQ)?
The most recent average sentiment score for AMARIN CORP PLC -ADR (AMRN:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for AMARIN CORP PLC -ADR (AMRN:NASDAQ)?
The most recent sentiment for AMARIN CORP PLC -ADR (AMRN:NASDAQ) is .
SEC-8K** Filing Available For AMARIN CORP PLC -ADR (AMRN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.